文献速递前列腺癌

术前PSMA PET阴性对前列腺癌淋巴结转移的预测价值

The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer.
PubMed 文献 · J Urol · 2021-02-03

回顾性分析434例接受PSMA PET及扩大盆腔淋巴结清扫的机器人辅助根治性前列腺切除术患者,评估PSMA PET阴性预测盆腔淋巴结转移的价值。总体阴性预测值为84.4%,中危患者为91.6%,高危患者为81.4%;中危且mpMRI分期<rT3者阴性预测值达98.1%。

要点

  • PSMA PET总体阴性预测值为84.4%,敏感度仅37.9%。
  • 中危患者阴性预测值91.6%,高危患者81.4%。
  • 中危且mpMRI<rT3者阴性预测值98.1%,可考虑省略淋巴结清扫。

核心结论

  • 高危前列腺癌患者PSMA PET阴性时仍常漏诊盆腔淋巴结转移,扩大盆腔淋巴结清扫仍是金标准分期方法。
  • 中危且mpMRI分期<rT3的患者,PSMA PET阴性可考虑省略扩大盆腔淋巴结清扫。

研究设计与样本

  • 回顾性分析434例术前接受PSMA PET、行机器人辅助根治性前列腺切除术及扩大盆腔淋巴结清扫的患者。
  • 排除PSMA PET显示远处转移的患者,主要结局为PSMA PET阴性预测盆腔淋巴结转移的价值。

主要发现

  • PSMA PET检测盆腔淋巴结转移的敏感度37.9%、特异度94.1%、阳性预测值64.3%、阴性预测值84.4%。
  • 中危患者阴性预测值91.6%(95% CI 86-97),高危患者81.4%(95% CI 77-86)。
  • 中危且mpMRI<rT3患者中,52例中51例PSMA PET真阴性,阴性预测值98.1%(95% CI 94-100)。

临床怎么用

  • 高危患者即使PSMA PET阴性,仍应行扩大盆腔淋巴结清扫。
  • 中危且mpMRI分期<rT3患者,若PSMA PET阴性,可考虑省略扩大盆腔淋巴结清扫。

局限性

  • 回顾性研究设计。
  • 排除PSMA PET显示远处转移的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We sought to identify a subset of patients in whom an extended pelvic lymph node dissection during robot-assisted laparoscopic radical prostatectomy for localized prostate cancer could be omitted when preoperative prostate specific membrane antigen positron emission tomography showed no lymph node metastatic prostate cancer. MATERIALS AND METHODS: A total of 434 patients who underwent prostate specific membrane antigen positron emission tomography prior to robot-assisted laparoscopic radical prostatectomy and extended pelvic lymph node dissection were retrospectively analyzed. Patients were excluded from analysis when the prostate specific membrane antigen positron emission tomography showed evidence of distant metastases. The primary outcome was whether a negative for metastases prostate specific membrane antigen positron emission tomography was able to correctly rule out pelvic lymp node metastases after extended pelvic lymph node dissection, ie its negative predictive value. RESULTS: Overall sensitivity, specificity, positive predictive value and negative predictive value of prostate specific membrane antigen positron emission tomography for the detection of pelvic lymp node metastases were 37.9%, 94.1%, 64.3% and 84.4%, respectively. The negative predictive value of prostate specific membrane antigen positron emission tomography in patients with intermediate risk prostate cancer was 91.6% (95% CI 86-97), compared to 81.4% (95% CI 77-86) in patients with high risk prostate cancer. When only assessing patients with <rT3 disease on multiparametric magnetic resonance imaging, 51/52 patients with intermediate risk prostate cancer had a true negative prostate specific membrane antigen positron emission tomography (negative predictive value=98.1%; 95% CI 94-100). CONCLUSIONS: In patients with high risk prostate cancer, extended pelvic lymph node dissection remains the gold standard staging method, as pelvic lymph node metastases are frequently missed in those with no lymph node metastatic prostate cancer on prostate specific membrane antigen positron emission tomography. Patients with intermediate risk prostate cancer and a radiological T-stage <rT3 on multiparametric magnetic resonance imaging are potential candidates to withhold an extended pelvic lymph node dissection in the presence of a "negative for lymph node metastases" prostate specific membrane antigen positron emission tomography.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Meijer D, de Barros HA, van Leeuwen PJ, et al. The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer. J Urol. 2021. PMID: 33530746. doi:10.1097/JU.0000000000001592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。